169 related articles for article (PubMed ID: 36271376)
1. Age in combination with gender is a valuable parameter in differential diagnosis of solid pseudopapillary tumors and pancreatic neuroendocrine neoplasm.
Wu L; Zou T; Shi D; Cheng H; Shahbaz M; Umar M; Li T; Zhang X; Gong P; Wei Y
BMC Endocr Disord; 2022 Oct; 22(1):255. PubMed ID: 36271376
[TBL] [Abstract][Full Text] [Related]
2. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of plasma chromogranin a in pancreatic neuroendocrine neoplasm.
Paik WH; Ryu JK; Song BJ; Kim J; Park JK; Kim YT; Yoon YB
J Korean Med Sci; 2013 May; 28(5):750-4. PubMed ID: 23678268
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a simple-to-use nomogram to predict liver metastasis in patients with pancreatic neuroendocrine neoplasms: a large cohort study.
Pan M; Yang Y; Teng T; Lu F; Chen Y; Huang H
BMC Gastroenterol; 2021 Mar; 21(1):101. PubMed ID: 33663420
[TBL] [Abstract][Full Text] [Related]
5. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound.
Liu Y; Shi S; Hua J; Xu J; Zhang B; Liu J; Yang XJ; Yu XJ
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):947-953. PubMed ID: 32144073
[TBL] [Abstract][Full Text] [Related]
7. The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study.
Wang C; Lin T; Chen X; Cui W; Guo C; Wang Z; Chen X
Cancer Biomark; 2023; 36(4):279-286. PubMed ID: 36938727
[TBL] [Abstract][Full Text] [Related]
8. The association between jaundice and poorly differentiated pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%).
Liu Y; Wang J; Zhou H; Wei Z; Wang J; Wang Z; Chen X
BMC Gastroenterol; 2023 Dec; 23(1):436. PubMed ID: 38087239
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.
Sadula A; Li G; Xiu D; Ye C; Ren S; Guo X; Yuan C
Comput Math Methods Med; 2022; 2022():3689895. PubMed ID: 35720036
[TBL] [Abstract][Full Text] [Related]
11. The Expression of Autophagy-Associated Genes Represents a Valid Footprint for Aggressive Pancreatic Neuroendocrine Neoplasms.
Matrood S; Melms LE; Bartsch DK; Di Fazio P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835048
[TBL] [Abstract][Full Text] [Related]
12. MRI-based radiomics approach for differentiation of hypovascular non-functional pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms of the pancreas.
Song T; Zhang QW; Duan SF; Bian Y; Hao Q; Xing PY; Wang TG; Chen LG; Ma C; Lu JP
BMC Med Imaging; 2021 Feb; 21(1):36. PubMed ID: 33622277
[TBL] [Abstract][Full Text] [Related]
13. Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.
Ito T; Hijioka S; Masui T; Kasajima A; Nakamoto Y; Kobayashi N; Komoto I; Hijioka M; Lee L; Igarashi H; Jensen RT; Imamura M
J Gastroenterol; 2017 Jan; 52(1):9-18. PubMed ID: 27539256
[TBL] [Abstract][Full Text] [Related]
14. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
[TBL] [Abstract][Full Text] [Related]
15. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
16. CD56 Expression Is Associated with Biological Behavior of Pancreatic Neuroendocrine Neoplasms.
Chen X; Guo C; Cui W; Sun K; Wang Z; Chen X
Cancer Manag Res; 2020; 12():4625-4631. PubMed ID: 32606955
[TBL] [Abstract][Full Text] [Related]
17. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
Kim YI; Kim SK; Paeng JC; Lee HY
Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
[TBL] [Abstract][Full Text] [Related]
18. Multimodality imaging differentiation of pancreatic neuroendocrine tumors and solid pseudopapillary tumors with a nomogram model: A large single-center study.
Hu HF; Li Z; Chen K; Liu MQ; Ye Z; Chen XM; Zhang Y; Yu XJ; Xu XW; Ji SR
Front Surg; 2022; 9():970178. PubMed ID: 36277293
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
[TBL] [Abstract][Full Text] [Related]
20. [Current diagnosis and treatment progress of small pancreatic neuroendocrine neoplasm].
Jiang JL; Wu WM; Zhao YP
Zhonghua Wai Ke Za Zhi; 2018 Dec; 56(12):951-956. PubMed ID: 30497122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
